UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 14 von 276
Datensatz exportieren als...
BibTeX
Generation of Novel Single-Chain Antibodies by Phage-Display Technology to Direct Imaging Agents Highly Selective to Pancreatic β- or α-Cells In Vivo
Diabetes (New York, N.Y.), 2009-10, Vol.58 (10), p.2324-2334
UEBERBERG, Sandra
MEIER, Juris J
SCHNEIDER, Stephan
WAENGLER, Carmen
SCHECHINGER, Wolfgang
DIETRICH, Johannes W
TANNAPFEL, Andrea
SCHMITZ, Inge
SCHIRRMACHER, Ralf
KÖLLER, Manfred
KLEIN, Harald H
2009
Volltextzugriff (PDF)
Details
Autor(en) / Beteiligte
UEBERBERG, Sandra
MEIER, Juris J
SCHNEIDER, Stephan
WAENGLER, Carmen
SCHECHINGER, Wolfgang
DIETRICH, Johannes W
TANNAPFEL, Andrea
SCHMITZ, Inge
SCHIRRMACHER, Ralf
KÖLLER, Manfred
KLEIN, Harald H
Titel
Generation of Novel Single-Chain Antibodies by Phage-Display Technology to Direct Imaging Agents Highly Selective to Pancreatic β- or α-Cells In Vivo
Ist Teil von
Diabetes (New York, N.Y.), 2009-10, Vol.58 (10), p.2324-2334
Ort / Verlag
Alexandria, VA: American Diabetes Association
Erscheinungsjahr
2009
Quelle
MEDLINE
Beschreibungen/Notizen
Generation of Novel Single-Chain Antibodies by Phage-Display Technology to Direct Imaging Agents Highly Selective to Pancreatic β- or α-Cells In Vivo Sandra Ueberberg 1 , Juris J. Meier 2 , Carmen Waengler 3 , 4 , Wolfgang Schechinger 1 , Johannes W. Dietrich 1 , Andrea Tannapfel 5 , Inge Schmitz 5 , Ralf Schirrmacher 4 , Manfred Köller 6 , Harald H. Klein 1 and Stephan Schneider 1 1 Department of Internal Medicine I, Division of Endocrinology and Metabolism, Berufsgenossenschaftliches University Hospital Bergmannsheil, Ruhr-University Bochum, Bochum, Germany; 2 Department of Internal Medicine I, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany; 3 Department of Nuclear Medicine, Hospital of the Ludwig-Maximilians-University, Munich, Germany; 4 Department of Neurology & Neurosurgery, Lady Davis Institute for Medical Research, McGill University, Montreal, Canada; 5 Institute for Pathology, Ruhr-University Bochum, Bochum, Germany; 6 Chirurgische Forschung, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum, Bochum, Germany. Corresponding author: Stephan Schneider, stephan.schneider{at}ruhr-unibochum.de . Abstract OBJECTIVE Noninvasive determination of pancreatic β-cell mass in vivo has been hampered by the lack of suitable β-cell–specific imaging agents. This report outlines an approach for the development of novel ligands homing selectively to islet cells in vivo. RESEARCH DESIGN AND METHODS To generate agents specifically binding to pancreatic islets, a phage library was screened for single-chain antibodies (SCAs) on rat islets using two different approaches. 1 ) The library was injected into rats in vivo, and islets were isolated after a circulation time of 5 min. 2 ) Pancreatic islets were directly isolated, and the library was panned in the islets in vitro. Subsequently, the identified SCAs were extensively characterized in vitro and in vivo. RESULTS We report the generation of SCAs that bind highly selective to either β- or α-cells. These SCAs are internalized by target cells, disappear rapidly from the vasculature, and exert no toxicity in vivo. Specific binding to β- or α-cells was detected in cell lines in vitro, in rats in vivo, and in human tissue in situ. Electron microscopy demonstrated binding of SCAs to the endoplasmatic reticulum and the secretory granules. Finally, in a biodistribution study the labeling intensity derived from [ 125 I]-labeled SCAs after intravenous administration in rats strongly predicted the β-cell mass and was inversely related to the glucose excursions during an intraperitoneal glucose tolerance test. CONCLUSIONS Our data provide strong evidence that the presented SCAs are highly specific for pancreatic β-cells and enable imaging and quantification in vivo. Footnotes The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Received May 4, 2009. Accepted July 3, 2009. © 2009 by the American Diabetes Association.
Sprache
Englisch
Identifikatoren
ISSN: 0012-1797
eISSN: 1939-327X
DOI: 10.2337/db09-0658
Titel-ID: cdi_pubmed_primary_19592622
Format
–
Schlagworte
Animals
,
Antibodies - analysis
,
Antibody Specificity
,
Apoptosis
,
Biological and medical sciences
,
Care and treatment
,
Cell Line
,
Cell Survival
,
Diabetes Mellitus, Experimental - pathology
,
Diabetes Mellitus, Experimental - physiopathology
,
Diabetes. Impaired glucose tolerance
,
Diagnosis
,
Endocrine pancreas. Apud cells (diseases)
,
Endocrinopathies
,
Endoplasmic Reticulum - immunology
,
Etiopathogenesis. Screening. Investigations. Target tissue resistance
,
Female
,
Genetic aspects
,
Glucagon-Secreting Cells - immunology
,
Glucagon-Secreting Cells - pathology
,
Glucagon-Secreting Cells - ultrastructure
,
Glucose Tolerance Test
,
Glucose tolerance tests
,
Humans
,
Immunohistochemistry
,
Insulin-Secreting Cells - immunology
,
Insulin-Secreting Cells - pathology
,
Insulin-Secreting Cells - ultrastructure
,
Medical sciences
,
Microscopy, Electron
,
Original
,
Pancreatic beta cells
,
Physiological aspects
,
Rats
,
Secretory Vesicles - immunology
,
Secretory Vesicles - pathology
,
Type 1 diabetes
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX